LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin

2007 ◽  
Vol 21 (9) ◽  
pp. 2086-2100 ◽  
Author(s):  
Haruka Sudo ◽  
Yoshiro Maru
2020 ◽  
Vol 22 (Supplement_2) ◽  
pp. ii32-ii32
Author(s):  
Charlotte Eaton ◽  
Paola Bisignano ◽  
David Raleigh

Abstract BACKGROUND Alterations in the NF2 tumor suppressor gene lead to meningiomas and schwannomas, but the tumor suppressor functions of the NF2 gene product, Merlin, are incompletely understood. To address this problem, we performed a structure-function analysis of Merlin by expressing cancer-associated missense single-nucleotide variants (mSNVs) in primary cancer cells for biochemical and cell biology experiments. METHODS All NF2 mSNVs were assembled from cBioPortal and COSMIC, and modelled on the FERM, a-helical, and C-terminal domains of Merlin (PDB 4ZRJ) using comparative structure prediction on the Robetta server and visually inspected using Pymol. mSNV hotspots were defined from sliding windows with at least 10 mutations within 5 residues in either direction. mSNVs from hotspots in meningiomas, schwannomas, or both, were selected for in vitro mechanistic analyses using immunofluorescence and immunoblotting of whole cell, plasma membrane, cytoskeletal, cytoplasmic, nuclear, and chromatin subcellular fractions from M10G meningioma cells and HEI-193 schwannoma cells. RESULTS We identified the following cancer-associated hotspot mSNVs in NF2, which were over-expressed for mechanistic studies: L46R, S156N, W191R, A211D, V219M, R418C and R462K. Endogenous Merlin was detected in all subcellular compartments, but was enriched in the nucleus. L46R and A211D mapped to hydrophobic pockets in the FERM domain, destabilized Merlin, and excluded Merlin from all subcellular compartments except the cytoskeleton. S156N, W191R and V219M also mapped to the FERM domain, but did not affect Merlin stability, and V219M attenuated chromatin localization, suggesting this motif may be involved in binding events that regulate subcellular localization. R418C and R463K mapped to the a-helical domain, but only R418C destabilized Merlin. CONCLUSION Our results suggest that cancer-associated mSNVs inactive the tumor suppressor functions of NF2 by altering the stability, subcellular localization, or binding partners of Merlin. Further work is required to identify and understand the impact of binding partners and subcellular localization on Merlin function.


2020 ◽  
Author(s):  
Hua Li ◽  
HyoungBin Oh ◽  
Benoit Viollet ◽  
Laura S. Schmidt ◽  
W. Marston Linehan ◽  
...  

AbstractTFE3 is an oncogenic transcription factor whose subcellular localization and activity are regulated by post-translational modifications. TFE3 is hyper-phosphorylated in the cytoplasm of mammalian cells under normal growth conditions, but becomes hypo-phosphorylated and translocates into the nucleus of cells with genetic inactivation of the FLCN tumor suppressor gene, which is responsible for the development of renal cancer, lung cysts and cutaneous hamartomas in patients with Birt-Hogg-Dubé syndrome (BHD). Since FLCN is suggested to play a role in metabolic signaling through its interaction with energy and nutrient sensing kinases AMPK and mTOR, we investigated whether metabolic signaling regulates TFE3 activity through post-translational modifications and subcellular localization. We found that TFE3 was activated by metabolic stresses, such as glucose or amino acid deprivation, and induced gene expression of lysosomal genes, cathepsins, V-ATPase and mucolipin-1. AMPK activation and/or mTORC1 inhibition by nutrient deprivation, AMPK activator, mTOR or lysosomal inhibitors induced hypo-phosphorylation and subsequent nuclear localization of TFE3. mTORC1 directly phosphorylated TFE3 in vitro and the mutation of a putative mTORC1-dependent TFE3 phosphorylation site, Ser 321, was critical for its interaction with 14-3-3 protein, and retention in the cytoplasm. Direct phosphorylation of TFE3 by AMPK was demonstrated by an in vitro kinase assay and the AMPK-mediated phosphorylation sites were determined by mass spectrometry; however, the physiological significance of AMPK-mediated TFE3 phosphorylation requires further investigation. mTORC1-mediated TFE3 phosphorylation under nutrient and growth factor replete conditions was dependent on FLCN expression. In summary, we have shown that TFE3 induces lysosomal gene expression upon activation of AMPK and inhibition_of mTORC1 activity by metabolic stresses or loss of FLCN, which would play important roles not only in catabolic processes but also in the pathogenicity of human disease including cancer.


2005 ◽  
Vol 375 (2) ◽  
pp. 81-86 ◽  
Author(s):  
Atsushi Shimomura ◽  
Kazuyoshi Kohu ◽  
Tetsu Akiyama ◽  
Takao Senda

2006 ◽  
Vol 175 (2) ◽  
pp. 305-313 ◽  
Author(s):  
Sarah C. Hughes ◽  
Richard G. Fehon

Merlin and Moesin are closely related members of the 4.1 Ezrin/Radixin/Moesin domain superfamily implicated in regulating proliferation and epithelial integrity, respectively. The activity of both proteins is regulated by head to tail folding that is controlled, in part, by phosphorylation. Few upstream regulators of these phosphorylation events are known. In this study, we demonstrate that in Drosophila melanogaster, Slik, a Ste20 kinase, controls subcellular localization and phosphorylation of Merlin, resulting in the coordinate but opposite regulation of Merlin and Moesin. These results suggest the existence of a novel mechanism for coordinate regulation of cell proliferation and epithelial integrity in developing tissues.


Sign in / Sign up

Export Citation Format

Share Document